Robert E. J. Ryder

5.0k total citations
167 papers, 3.2k citations indexed

About

Robert E. J. Ryder is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Robert E. J. Ryder has authored 167 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Molecular Biology and 30 papers in Surgery. Recurrent topics in Robert E. J. Ryder's work include Diabetes Treatment and Management (55 papers), Diabetes Management and Research (31 papers) and Metabolism, Diabetes, and Cancer (26 papers). Robert E. J. Ryder is often cited by papers focused on Diabetes Treatment and Management (55 papers), Diabetes Management and Research (31 papers) and Metabolism, Diabetes, and Cancer (26 papers). Robert E. J. Ryder collaborates with scholars based in United Kingdom, United States and Australia. Robert E. J. Ryder's co-authors include Ansu Basu, Andrew Hunter, J. Lowell, T M Hayes, David Steel, David R. Owens, Lee Kennedy, E. J. Fletcher, R.L. Kennedy and NG Testa and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Robert E. J. Ryder

157 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. J. Ryder United Kingdom 30 1.1k 776 674 559 484 167 3.2k
Chris Andrews United States 35 280 0.3× 621 0.8× 745 1.1× 176 0.3× 827 1.7× 151 3.5k
Craig Kollman United States 35 2.7k 2.6× 676 0.9× 565 0.8× 1.7k 3.0× 212 0.4× 80 5.5k
Matthew Davis United States 15 308 0.3× 1.9k 2.4× 2.1k 3.2× 112 0.2× 249 0.5× 45 3.3k
Delphine Maucort‐Boulch France 35 132 0.1× 200 0.3× 186 0.3× 1.1k 2.0× 543 1.1× 176 4.7k
Linda Williams United Kingdom 34 364 0.3× 440 0.6× 71 0.1× 2.4k 4.3× 1.4k 2.8× 120 6.4k
Barry Pizer United Kingdom 36 124 0.1× 321 0.4× 147 0.2× 582 1.0× 1.4k 2.9× 192 4.5k
Ian N Bruce United Kingdom 59 207 0.2× 1.9k 2.5× 124 0.2× 429 0.8× 1.2k 2.6× 310 12.1k
Antonella Afeltra Italy 36 132 0.1× 457 0.6× 30 0.0× 510 0.9× 564 1.2× 196 4.3k
Young Deuk Choi South Korea 39 276 0.3× 463 0.6× 61 0.1× 2.0k 3.6× 984 2.0× 362 6.0k
Jorge Quiroga Spain 42 532 0.5× 249 0.3× 113 0.2× 1.6k 2.8× 573 1.2× 190 5.4k

Countries citing papers authored by Robert E. J. Ryder

Since Specialization
Citations

This map shows the geographic impact of Robert E. J. Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. J. Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. J. Ryder more than expected).

Fields of papers citing papers by Robert E. J. Ryder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. J. Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. J. Ryder. The network helps show where Robert E. J. Ryder may publish in the future.

Co-authorship network of co-authors of Robert E. J. Ryder

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. J. Ryder. A scholar is included among the top collaborators of Robert E. J. Ryder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. J. Ryder. Robert E. J. Ryder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deshmukh, Harshal, Kazeem Adeleke, Emma G. Wilmot, et al.. (2024). Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study. Diabetes Obesity and Metabolism. 26(4). 1333–1339. 2 indexed citations
2.
Crabtree, Thomas, Lalantha Leelarathna, Peter Hammond, et al.. (2024). Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study. Diabetes Research and Clinical Practice. 209. 111597–111597. 2 indexed citations
3.
Ssemmondo, Emmanuel, Harshal Deshmukh, Emma G. Wilmot, et al.. (2024). Effect of intermittently scanned continuous glucose monitoring in people with diabetes with a psychosocial indication for initiation. Diabetes Obesity and Metabolism. 26(4). 1340–1345. 2 indexed citations
4.
Fogden, Edward, et al.. (2024). Endoscopic duodenal‐jejunal bypass liner treatment of moderate obstructive sleep apnoea—A pilot study. Clinical Obesity. 14(6). e12694–e12694. 1 indexed citations
5.
Adamson, Karen, Alex Bickerton, Alison Evans, et al.. (2023). factors predicting glucose and weight response to injectable semaglutide (Ozempic): real-world data from the Association of British Clinical Diabetologists’ audit programme. British Journal of Diabetes. 23(2). 94–100. 3 indexed citations
6.
Deshmukh, Harshal, Emma G. Wilmot, Neil Walker, et al.. (2023). Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit. Diabetes Obesity and Metabolism. 26(1). 46–53. 2 indexed citations
7.
Field, Benjamin C. T., Yue Ruan, Jim Davies, et al.. (2023). A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID ‐19. Diabetes Obesity and Metabolism. 25(7). 2012–2022. 1 indexed citations
8.
9.
10.
Ryder, Robert E. J.. (2007). Rosiglitazone versus pioglitazone in relation to cardiovascular disease in type 2 diabetes: primum non nocere. Practical Diabetes International. 24(8). 422–425. 3 indexed citations
11.
Hancock, Bruno C., John Radford, M.H. Cullen, et al.. (2004). Randomised controlled trial of ABVD vs. two multi-drug regimens (MDRs) for advanced Hodgkin's lymphoma (HL): Initial results of UKLG LY09 (ISRCTN97144519).. British Journal of Cancer. 91. 1 indexed citations
12.
Radford, John, M.H. Cullen, Matthew R. Sydes, et al.. (2003). Randomised comparison of ABVD with two multi-drug regimens (MDRs) in the treatment of advanced Hodgkin lymphoma (HL): Initial results of the UKLG LY09 study (ISRCTN 97144519).. Blood. 102(11). 2 indexed citations
13.
Feinstein, David, Michael Doran, Robert E. J. Ryder, & William A. Ward. (1999). Proceedings of the 37th annual Southeast regional conference (CD-ROM).
14.
Anderson, Heather, J.H. Scarffe, Malcolm Ranson, et al.. (1995). VAD chemotherapy as remission induction for multiple myeloma. British Journal of Cancer. 71(2). 326–330. 69 indexed citations
15.
Ryder, Robert E. J. & H. Campbell. (1995). Natural family planning in the 1990s. The Lancet. 346(8969). 233–234. 10 indexed citations
16.
Ryder, Robert E. J., M Dent, & J. D. Ward. (1992). Testing for diabetic neuropathy, part two: Autonomic neuropathy. Practical Diabetes International. 9(2). 56–60. 2 indexed citations
17.
Ryder, Robert E. J., David R. Owens, T M Hayes, M.A. Ghatei, & S. R. Bloom. (1990). Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.. BMJ. 301(6755). 783–787. 69 indexed citations
18.
Ryder, Robert E. J., et al.. (1985). Possible new method to improve detection of diabetic retinopathy: Polaroid non-mydriatic retinal photography.. BMJ. 291(6504). 1256–1257. 49 indexed citations
19.
Ryder, Robert E. J., et al.. (1985). Screening for diabetic retinopathy. BMJ. 290(6478). 1349.2–1349. 2 indexed citations
20.
Ryder, Robert E. J., T M Hayes, I. P. Mulligan, et al.. (1984). How soon after myocardial infarction should plasma lipid values be assessed?. BMJ. 289(6459). 1651–1653. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Andrews Breakdown of academic impact, for papers by Craig Kollman Breakdown of academic impact, for papers by Matthew Davis Breakdown of academic impact, for papers by Delphine Maucort‐Boulch Breakdown of academic impact, for papers by Linda Williams Breakdown of academic impact, for papers by Barry Pizer Breakdown of academic impact, for papers by Ian N Bruce Breakdown of academic impact, for papers by Antonella Afeltra Breakdown of academic impact, for papers by Young Deuk Choi Breakdown of academic impact, for papers by Jorge Quiroga
Rankless by CCL
2026